Q4 2014 Holdings
Filed 2015-02-13 | 36 holdings | $23.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $12.7M | 113,500 | 55.4% |
| Codexis Inc(CDXS) | COM | 192005106 | $4.3M | 1,724,000 | 18.9% |
| Catalyst Pharm Partners Inc(CPRX) | COM | 14888U101 | $2.9M | 975,000 | 12.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $2.8M | 29,100 | 12.3% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $32.4K | 805,000 | 0.1% |
| Cempra Inc | COM | 15130J109 | $11.9K | 504,800 | 0.1% |
| Retrophin Inc | COM | 761299106 | $11.3K | 920,000 | 0.0% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $10.5K | 1,525,000 | 0.0% |
| Pharmacyclics Inc | COM | 716933106 | $10.4K | 85,000 | 0.0% |
| Clovis Oncology Inc.(CLVSEUR) | COM | 189464100 | $7.8K | 140,000 | 0.0% |
| Tetraphase Pharmaceuticals Inc | COM | 88165N105 | $7.5K | 189,700 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $5.9K | 1,825,000 | 0.0% |
| Versartis Inc | COM | 92529L102 | $5.3K | 235,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $5.2K | 191,338 | 0.0% |
| Insys Therapeutics Inc New | COM NEW | 45824V209 | $5.2K | 122,500 | 0.0% |
| Ultragenyx Pharmaceuticals Inc(RARE) | COM | 90400D108 | $4.7K | 106,200 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $4.6K | 335,000 | 0.0% |
| Ophthotech Corp | COM | 683745103 | $4.5K | 100,000 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $4.4K | 76,000 | 0.0% |
| Medgenics Inc | COM NEW | 58436Q203 | $4.3K | 850,000 | 0.0% |
| Imprimis Pharmaceuticals Inc | COM NEW | 45323A201 | $4.2K | 560,000 | 0.0% |
| Oncothyreon Inc | COM | 682234108 | $3.8K | 2,000,000 | 0.0% |
| Cardiovascular SYS Inc del(CSIIEUR) | COM | 141619106 | $3.8K | 125,000 | 0.0% |
| Flamel Technologies SA | COM | 338488109 | $3.5K | 205,000 | 0.0% |
| Fluidigm Corp del(LAB) | COM | 34385P108 | $3.2K | 95,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $3.1K | 80,000 | 0.0% |
| Trillium Therapeutics Inc | COM | 89620X506 | $3.0K | 333,333 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $2.9K | 350,000 | 0.0% |
| Horizon Pharma PLC | COM | G4617B105 | $2.8K | 220,000 | 0.0% |
| Accelerate Diagnostics | COM | 00430H102 | $1.9K | 100,000 | 0.0% |
| Celgene Corp | RIGHT 12/31/2030 | 151020112 | $1.8K | 575,000 | 0.0% |
| Tenax Therapeutics Inc | COM | 88032L100 | $1.7K | 440,000 | 0.0% |
| Evoke Pharma Inc | COM | 30049G104 | $1.4K | 240,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $1.0K | 45,000 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $798 | 80,000 | 0.0% |
| Biolinerx LTD | COM | 09071M106 | $405 | 250,000 | 0.0% |